Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02907359
Title Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | ITA | GBR | FRA | ESP | DNK | DEU | CZE | CAN | BEL


No variant requirements are available.